Total Prostate-Specific Antigen


Test Overview

The Total PSA (Prostate-Specific Antigen) test measures the overall level of PSA, a protein produced by the prostate gland, in the blood. PSA is present in small amounts in healthy men, but elevated levels can indicate various prostate conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. This test is commonly used as a screening tool for prostate cancer, especially in men over 50 or those with a family history of the disease. PSA levels naturally increase with age, so results must be interpreted in the context of individual risk factors. If PSA levels are elevated, additional tests, such as Free PSA or a biopsy, may be recommended.


Test Types

  • Total PSA Test: Measures the total amount of PSA (both bound and free forms) in the blood.
  • Free PSA Test: Measures the portion of PSA that is not bound to proteins. A lower free PSA percentage may indicate a higher risk of prostate cancer.
  • PSA Ratio (Free PSA/Total PSA): Helps tell between benign prostate conditions and prostate cancer.

Total PSA Test Results & Ranges

Test Component:Normal Range:Abnormal (Possible Conditions):
Total PSA0–4.0 ng/mLHigh: Prostate Cancer, Benign Prostatic Hyperplasia (BPH), Prostatitis

 

Age-Specific PSA Ranges (General Guidelines):

Age GroupNormal PSA Range
40–49 years0.0–2.5 ng/mL
50–59 years0.0–3.5 ng/mL
60–69 years0.0–4.5 ng/mL
70+ years0.0–6.5 ng/mL

 


Expected Turnaround Time

  • Results Available: 1–2 business days

Specimen Requirements

  • Sample Type: Blood sample (venipuncture)
  • Container: Serum separator tube (SST) or plain tube

Collection Instructions

  1. Fasting is not required, but some laboratories may suggest fasting to standardize results.
  2. Avoid ejaculation for 24–48 hours before the test, as it can temporarily raise PSA levels.
  3. Avoid recent prostate procedures (such as digital rectal exam, prostate biopsy, or cystoscopy) as these can elevate PSA levels.
  4. Inform your healthcare provider of any medications (e.g., finasteride, dutasteride) as they can artificially lower PSA levels.
  • Storage: Blood samples should be processed promptly and stored according to lab protocols, typically refrigerated or at room temperature until testing.

Test Details

Clinical Use: Prostate Cancer Screening: Helps detect early-stage prostate cancer in men at risk. Prostate Health Evaluation: Assesses conditions like benign prostatic hyperplasia (BPH) and prostatitis. Cancer Monitoring: Tracks PSA levels in patients undergoing treatment for prostate cancer or monitoring recurrence after surgery or radiation therapy.

Limitations: PSA levels can be affected by various factors, including age, prostate size, recent sexual activity, inflammation, and certain medications. Elevated PSA levels do not necessarily indicate cancer, as BPH and prostatitis can also raise PSA levels. False positives and false negatives can occur, so PSA testing is often combined with digital rectal exams (DRE) and, if necessary, prostate biopsies for accurate diagnosis.


The Total PSA Test is a crucial tool in prostate health assessment, used for screening, diagnosis, and monitoring of prostate-related conditions.


0